UBS is a global financial institution built around its core strength in wealth management, serving high and ultra-high-net-worth individuals... Show more
In recent trading sessions, UBS Group AG (UBS) stock has displayed resilience amid fluctuating sentiment driven by domestic regulatory discussions and broader sector dynamics. Shares have oscillated within a familiar range, reflecting investor focus on the bank's capital position and upcoming results. Supported by strong assets under management (AUM) growth in wealth management and stabilizing investment banking fees, the stock maintains attractive valuation metrics, including a trailing P/E ratio around 17.6. Trading volume has picked up during key news flows, underscoring keen interest from institutional players as the bank positions for sustained profitability.
Tickeron’s Trending AI Robots page showcases the top 25 performers curated from over 350 AI trading bots that analyze thousands of tickers across diverse strategies and timeframes. These bots employ advanced machine learning, blending technical and fundamental analysis for signals in trend following, corridor trading with take-profit/stop-loss exits, and sector-specific plays. Standout stats include annualized returns ranging from +15% to +168%, win rates of 48%–88%, and profit factors up to 11.7, with average trade durations from minutes to weeks and drawdowns managed effectively (e.g., profit-to-drawdown ratios over 20). While none specifically target UBS, several excel in financial stocks like Goldman Sachs (GS) and Morgan Stanley (MS), alongside semiconductors and leveraged ETFs—ideal for volatile banking conditions. Explore these high-performing bots to enhance your trading toolkit with data-driven insights tailored to current markets.
UBS Group AG (UBS) stock has been shaped by a series of regulatory, corporate, and earnings-related events over the past 30 days, leading to notable price swings. Late March saw shares climb around 3% after reports that Swiss lawmakers were considering softer capital rules for systemically important banks, easing fears of stringent post-Credit Suisse merger requirements. This positive sentiment propelled the stock higher, reflecting relief over potential moderation in too-big-to-fail (TBTF) measures.
On April 15, UBS held its Annual General Meeting (AGM) in Basel, approving a proposed USD 1.10 per share dividend payable around April 22 and nominating new board members, including former Bank for International Settlements head Agustín Carstens. The agenda also covered compensation approvals, signaling continuity in governance amid integration efforts. Shares traded steadily around the event, closing near $43 post-AGM, supported by the dividend hike from prior years.
Regulatory headwinds reemerged in late April. On April 22, UBS issued a statement responding to Swiss government announcements on capital rules, noting no immediate changes before 2027 and reaffirming its underlying return on tangible equity (ROTCE—a profitability metric excluding intangibles) targets above 15%. However, the prior day's unveiling of a bill to raise capital requirements drew investor backlash, with shares dropping over 3% on April 23 as UBS underperformed banking peers. Analysts highlighted concerns over potential increases in Common Equity Tier 1 (CET1—the core capital ratio for banks) demands, possibly up to $20–26 billion in additional buffers, though a long transition mitigates short-term pressure.
Anticipation builds for Q1 2026 results on April 29, with consensus eyeing $11 billion in revenue and $1.5–2.4 billion net profit, fueled by investment banking recovery and cost discipline post-Credit Suisse integration. This follows Credit Suisse migration completion, boosting operational efficiency. Price action reflects these dynamics: gains on softer rule signals, dips on stricter proposals, and stability around corporate milestones, with the stock hovering near $41–43 amid heightened volume.
As UBS Group AG advances through 2026, investors should track Swiss regulatory evolution, particularly TBTF proposals and CET1 impacts, with implementation likely post-2027 allowing adaptation time. Completion of Credit Suisse integration positions the bank for AUM expansion in wealth management amid global wealth growth trends, while net interest income (NII—earnings from loans minus deposits) faces normalization as rates potentially ease.
Investment banking fees could benefit from M&A (mergers and acquisitions) upticks and equity capital markets activity, supported by economic acceleration in H2. Cost controls and ROTCE targets remain pivotal, alongside non-core asset reductions (NCO ratio for credit losses). Macro risks like geopolitical tensions and trade policies loom, but UBS's $7 trillion+ invested assets and diversified footprint offer buffers. Competitive positioning in Asia and sustainable finance will be crucial, balanced against litigation tailwinds from legacy exposures.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 50-day moving average for UBS moved above the 200-day moving average on May 18, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on UBS as a result. In of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 340 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 304 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UBS moved out of overbought territory on May 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 53 cases where UBS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on May 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBS broke above its upper Bollinger Band on June 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 24, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.740) is normal, around the industry mean (1.823). P/E Ratio (17.552) is within average values for comparable stocks, (14.944). UBS's Projected Growth (PEG Ratio) (0.888) is slightly lower than the industry average of (1.669). Dividend Yield (0.023) settles around the average of (0.025) among similar stocks. P/S Ratio (3.257) is also within normal values, averaging (3.878).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks